A compound of Formula (I), or a stereoisomer or a pharmaceutically acceptable salt thereof: wherein: B is selected from: (a) hydrogen, (b) halogen, (c) C 1 -C 6 alkyl, (d) OR 1 , (e) NR 1 R 2 , (f) SH, (g) SR 1 , (h) SOR 1 , (i) SO 2 R 1 , (j) CHO, (k) COOR 1 , (l) CONR 1 R 2 , (m) CN, (n) heteroaryl, (o) heterocycloalkyl, or (P) NHC(=NH)NH 2 ; R 1 and R 2 are each independently: (a) hydrogen, (b) C 1 -C 6 alkyl, optionally substituted with one or more substituents independently selected from CN, halogen, OH, NH 2 , COOH, CONH 2 , SH, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl, (c) three to seven membered cycloalkyl, optionally substituted with one or more substituents independently selected from CN, halogen, OH, NH 2 , COOH, CONH 2 , or SH, (d) three to seven membered heterocycloalkyl, optionally substituted with one or more substituents independently selected from CN, halogen, OH, NH 2 , COOH, CONH 2 , or SH, (e) six to fourteen membered aryl, optionally substituted with one or more substituents independently selected from CN, halogen, OH, NH 2 , COOH, CONH 2 , or SH, or (f) five to fourteen membered heteroaryl, optionally substituted with one or more substituents independently selected from CN, halogen, OH, NH 2 , COOH, CONH 2 , SH; M is selected from: (a) hydrogen, (b) C 1 -C 6 alkyl, or (c) a pharmaceutically accepted salt forming cation independently selected from Na, K, or Ca. B is selected from: (a) hydrogen, (b) halogen, (c) C 1 -C 6 alkyl, (d) OR 1 , (e) NR 1 R 2 , (f) SH, (g) SR 1 , (h) SOR 1 , (i) SO 2 R 1 , (j) CHO, (k) COOR 1 , (l) CONR 1 R 2 , (m) CN, (n) heteroaryl, (o) heterocycloalkyl, or (P) NHC(=NH)NH 2 ; (a) hydrogen, (b) halogen, (c) C 1 -C 6 alkyl, (d) OR 1 , (e) NR 1 R 2 , (f) SH, (g) SR 1 , (h) SOR 1 , (i) SO 2 R 1 , (j) CHO, (k) COOR 1 , (l) CONR 1 R 2 , (m) CN, (n) heteroaryl, (o) heterocycloalkyl, or (P) NHC(=NH)NH 2 ; R 1 and R 2 are each independently: (a) hydrogen, (b) C 1 -C 6 alkyl, optionally substituted with one or more substituents independently selected from CN, halogen, OH, NH 2 , COOH, CONH 2 , SH, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl, (c) three to seven membered cycloalkyl, optionally substituted with one or more substituents independently selected from CN, halogen, OH, NH 2 , COOH, CONH 2 , or SH, (d) three to seven membered heterocycloalkyl, optionally substituted with one or more substituents independently selected from CN, halogen, OH, NH 2 , COOH, CONH 2 , or SH, (e) six to fourteen membered aryl, optionally substituted with one or more substituents independently selected from CN, halogen, OH, NH 2 , COOH, CONH 2 , or SH, or (f) five to fourteen membered heteroaryl, optionally substituted with one or more substituents independently selected from CN, halogen, OH, NH 2 , COOH, CONH 2 , SH; (a) hydrogen, (b) C 1 -C 6 alkyl, optionally substituted with one or more substituents independently selected from CN, halogen, OH, NH 2 , COOH, CONH 2 , SH, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl, (c) three to seven membered cycloalkyl, optionally substituted with one or more substituents independently selected from CN, halogen, OH, NH 2 , COOH, CONH 2 , or SH, (d) three to seven membered heterocycloalkyl, optionally substituted with one or more substituents independently selected from CN, halogen, OH, NH 2 , COOH, CONH 2 , or SH, (e) six to fourteen membered aryl, optionally substituted with one or more substituents independently selected from CN, halogen, OH, NH 2 , COOH, CONH 2 , or SH, or (f) five to fourteen membered heteroaryl, optionally substituted with one or more substituents independently selected from CN, halogen, OH, NH 2 , COOH, CONH 2 , SH; M is selected from: (a) hydrogen, (b) C 1 -C 6 alkyl, or (c) a pharmaceutically accepted salt forming cation independently selected from Na, K, or Ca. (a) hydrogen, (b) C 1 -C 6 alkyl, or (c) a pharmaceutically accepted salt forming cation independently selected from Na, K, or Ca. <EOS>